These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6163417)

  • 61. [Interferon: facts and hopes. I. Properties of interferon].
    Dmoszyńska-Giannopoulou A; Rupniewska ZM
    Pol Arch Med Wewn; 1981 Oct; 66(4):303-6. PubMed ID: 6174953
    [No Abstract]   [Full Text] [Related]  

  • 62. The clinical value of interferon--a critical appraisal.
    Billiau A; de Somer P; Schellekens H; Weimar W
    Neth J Med; 1981; 24(2):72-8. PubMed ID: 6165902
    [No Abstract]   [Full Text] [Related]  

  • 63. [Interferon against cancer?].
    Gallmeier WM
    MMW Munch Med Wochenschr; 1980 Sep; 122(37):1261-4. PubMed ID: 6158683
    [No Abstract]   [Full Text] [Related]  

  • 64. [The role and therapeutic use of interferons in leishmaniasis (a review of the literature)].
    Fediainova IE
    Med Parazitol (Mosk); 1992; (5-6):57-61. PubMed ID: 1284397
    [No Abstract]   [Full Text] [Related]  

  • 65. Human lymphoblastoid cells as a source of interferon.
    Finter NB; Fantes KH; Johnston M
    Dev Biol Stand; 1977 Apr 13-15; 38():343-8. PubMed ID: 608522
    [TBL] [Abstract][Full Text] [Related]  

  • 66. On the mechanisms of the antitumor effects of interferon.
    Gresser I
    Tex Rep Biol Med; 1981-1982; 41():582-9. PubMed ID: 6189223
    [No Abstract]   [Full Text] [Related]  

  • 67. Interferon effects on the growth and division of human fibroblasts.
    Pfeffer LM; Murphy JS; Tamm I
    Exp Cell Res; 1979 Jun; 121(1):111-20. PubMed ID: 446522
    [No Abstract]   [Full Text] [Related]  

  • 68. Enhancement of carcinoembryonic antigen expression by interferon.
    Attallah AM; Needy CF; Noguchi PD; Elisberg BL
    Int J Cancer; 1979 Jul; 24(1):49-52. PubMed ID: 478691
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interactions between body fluids, chemotherapeutic agents and interferon.
    Cesario TC; Tilles JG
    Tex Rep Biol Med; 1981-1982; 41():259-62. PubMed ID: 6184812
    [No Abstract]   [Full Text] [Related]  

  • 70. Effect of leukocyte interferon on urinary excretion of cytomegalovirus by infants.
    Arvin AM; Yeager AS; Merigan TC
    J Infect Dis; 1976 Jun; 133 Suppl():A205-10. PubMed ID: 180201
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Experience with using leukocytic interferon with methacil in influenza in children].
    Strutsovskaia AL; Ulanovskaia TI; Furer NM; Ermol'eva ZV
    Antibiotiki; 1975 Feb; 20(2):170-3. PubMed ID: 123426
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interferons.
    Higgins PG
    J Clin Pathol; 1984 Feb; 37(2):109-16. PubMed ID: 6198337
    [No Abstract]   [Full Text] [Related]  

  • 73. [Clinical use of interferon and its inducers].
    Nosik NN; Ershov FI
    Antibiotiki; 1980 Sep; 25(9):695-710. PubMed ID: 6158289
    [No Abstract]   [Full Text] [Related]  

  • 74. [Interferon from the laboratory to clinical use].
    Cantell K
    Duodecim; 1978; 94(11):689-96. PubMed ID: 688904
    [No Abstract]   [Full Text] [Related]  

  • 75. [Pharmacological study of human leukocytic interferon].
    Scherbakova EG; Eĭdelshteĭn SI; Furer NM
    Antibiotiki; 1973 Mar; 18(3):256-9. PubMed ID: 4357951
    [No Abstract]   [Full Text] [Related]  

  • 76. Interferon in the treatment of osteogenic sarcoma.
    Shoham J
    Prog Clin Biol Res; 1982; 99():83-105. PubMed ID: 6183679
    [No Abstract]   [Full Text] [Related]  

  • 77. Interferon and the central nervous system.
    Dafny N; Yang PB
    Eur J Pharmacol; 2005 Oct; 523(1-3):1-15. PubMed ID: 16226745
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The pharmacokinetics of interferons].
    Ogarkov VI; Lapina GF
    Antibiot Med Biotekhnol; 1986 Sep; 31(9):712-5. PubMed ID: 2430520
    [No Abstract]   [Full Text] [Related]  

  • 79. Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial.
    Borden EC; Holland JF; Dao TL; Gutterman JU; Wiener L; Chang YC; Patel J
    Ann Intern Med; 1982 Jul; 97(1):1-6. PubMed ID: 6178335
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biological properties of natural and recombinant interferons.
    Pestka S; Evinger M; Maeda S; Rehberg E; Familletti PC; Kelder B
    Tex Rep Biol Med; 1981-1982; 41():31-6. PubMed ID: 6184819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.